21 results
SC 13D/A
EX-3
IDXG
Interpace Biosciences, Inc.
21 Jan 21
INTERPACE BIOSCIENCES / 1315 Capital II ownership change
4:49pm
10-K
2019 FY
EX-3.1
IDXG
Interpace Biosciences, Inc.
Annual report
22 Apr 20
11:56am
8-K
EX-3.1
IDXG
Interpace Biosciences, Inc.
17 Jan 20
Entry into a Material Definitive Agreement
8:30am
8-K
EX-3.1
IDXG
Interpace Biosciences, Inc.
14 Jan 20
Amendments to Articles of Incorporation or Bylaws
12:55pm
8-K
EX-3.2
lslk29vvpuqx48symn7m
14 Nov 19
Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results
4:13pm
8-K
EX-3.1
liygcfz0h
14 Nov 19
Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results
4:13pm
8-K
EX-3.1
vop7i9
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-3.1
v03o8t4t4wte8si
28 Dec 16
Interpace Diagnostics Group Announces 1-for-10 Reverse Split
12:00am
8-K
EX-3.1
nbhkiuvfu9iwl nwf
23 Dec 15
Termination of a Material Definitive Agreement
12:00am
8-K
EX-3.2
lg7qbzb8g1lpxsr9
23 Dec 15
Termination of a Material Definitive Agreement
12:00am
10-K405
EX-3.3
5489vsm9
13 Mar 02
Annual report (delinquent filer disclosure)
12:00am
S-1
EX-3.1
wynf12o9fo5 k72o6v
13 Feb 98
IPO registration
12:00am